SETD2 and cancer: The activation or intensification of cancer cells' mitochondrial metabolism through hypoxia-inducible factor-1 α (HIF-1 α) and pyruvate dehydrogenase kinase-3 (PDK) (by nuclear accumbens-1 and dichloroacetate (DCA)) reduce the glycolysis of cancer cells.